Why Is LUMEXA IMAGING HLDGS (LMRI) Stock Moving Today?
LUMEXA IMAGING HLDGS (LMRI) is drawing unusual attention today. Our newswire has captured 2 stories on LMRI across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 57/100).
Lumexa Imaging Holdings (LMRI) shares rose 14.58% to $15.95, driven by a strong third quarter earnings report and a significant upgrade in fiscal 2026 guidance. The company posted results that exceeded analyst expectations, prompting immediate positive reactions from Wall Street analysts.
What Happened
Lumexa reported third quarter non-GAAP EPS of $0.26, beating the consensus estimate of $0.18 by $0.08. Revenue came in at $272 million, up 5.1% year over year and exceeding estimates by $2.11 million. The company narrowed its adjusted EBITDA guidance for fiscal 2026 to a range of $236 million to $240 million. Management raised its adjusted EPS guidance for the full year from a previous range of $0.71 to $0.77 to a new range of $0.86 to $0.90, well above the prior estimate of $0.77. The company also reaffirmed its fiscal 2026 sales guidance of $1.045 billion to $1.097 billion. Raymond James raised its price target for the stock from $17 to $19 following the earnings beat. The company outlined a target of at least 30% free cash flow conversion for 2026 while identifying a total addressable market of roughly $77 billion.
What The Data Shows
The stock has gained 22.0% over the last eight sessions, moving from $11.41 to $13.92 before the latest jump. Lumexa printed six fresh 52-week highs and one fresh 52-week low on November 11, 2026. The company currently has a market capitalization of $1.3 billion. It remains unprofitable on a trailing twelve-month basis with an EPS of negative $0.33 and a net margin of negative 2.7%. Revenue growth stands at 7.8% on a trailing twelve-month basis. The 52-week range for the stock is $6.45 to $19.45.
What To Watch
Investors will monitor the company's progress toward its raised adjusted EPS guidance and its ability to achieve the targeted free cash flow conversion rate in the coming quarters.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LMRI by the numbers
The headlines behind the move
Lumexa Imaging Holdings Inc (LMRI) Q3 2026 Earnings Call Highlights: Revenue Climbs 5%, Adjusted EBITDA Rises 11% Sequentially, and Free Cash Flow Guidance Raised
Frequently asked questions
Why is LMRI stock moving today?
LUMEXA IMAGING HLDGS (LMRI) is drawing unusual attention today. Our newswire has captured 2 stories on LMRI across 1 source in the last 36 hours, with AI sentiment reading mixed (avg 57/100). The most recent driver: "LMRI SWOT Analysis: Financial Resilience Amidst Challenges Revealed in 10-Q Filing" (GuruFocus).
Is LMRI a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of LMRI coverage reads 57/100 over 2 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is LFTO up today (+30.63%)
- Why is MOD up today (+27.86%)
- Why is HAWK up today (+23.79%)
- Why is HTFL down today (-19.13%)
- Why is VIR down today (-17.82%)
- Why is TNDM up today (+14.62%)
More on LMRI: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier LMRI move explainers: 2026-11-12 · 2026-11-11